ASTAGRAF XL
tacrolimus extended-release capsules
- Strength
- .5 mg/1
- Form
- Capsule, Coated, Extended Release
- Class
- Calcineurin Inhibitor Immunosuppressant
Astellas Pharma US, Inc.
Listed by Glenmark Pharmaceuticals Inc., USA
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Calcineurin Inhibitor Immunosuppressant |
| Approval route | ANDA — approved generic |
| NDC code | 68462-686 |
| FDA application | ANDA206662 |
| RxNorm concept | 198377 |
| Package sizes listed | 2 |
| Marketed since | November 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
tacrolimus extended-release capsules
Astellas Pharma US, Inc.
tacrolimus extended-release capsules
Astellas Pharma US, Inc.
tacrolimus extended-release capsules
Astellas Pharma US, Inc.
Tacrolimus
Veloxis Pharmaceuticals, Inc
Tacrolimus
Veloxis Pharmaceuticals, Inc
Tacrolimus
Veloxis Pharmaceuticals, Inc
Tacrolimus
Astellas Pharma US, Inc.
Tacrolimus
Astellas Pharma US, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.